Operation Warp Speed expects that the U.S. trials of vaccines made by AstraZeneca Plc and Johnson & Johnson to restart as soon as this week. The two companies developing Covid-19 vaccines backed by Operation Warp Speed temporarily halted their trials because participants fell ill, slowing down the race for a shot to halt the pandemic. J&J paused its trial last week when a participant got sick. AstraZeneca’s trial paused last month after a woman in the U.K. study developed neurological symptoms and the U.S. Food & Drug Administration has yet to clear the study to resume in the U.S. Johnson & Johnson is testing its vaccine in as many as 60,000 volunteers from Peru to South Africa. U.S. regulators have not put a clinical hold on J&J’s trial. British drugmaker Astra and partner the University of Oxford last month temporarily stopped tests of its own vaccine candidate after a trial participant fell ill. While the Astra study has remained halted in the U.S., where it is being evaluated by regulators, it has resumed in a number of other countries.
SOURCE: AL JAZEERA
More Stories
Lagos Rising: Meet the African Designers Who are Ushering in a New Guard of Fashion
My Life in Food: Idris Elba on African Cuisine and Cooking with his Mum
In His Imaginative Debut Feature, Walé Oyéjidé Brings Together Elements of His Life’s Work
What is Zellige Tile?
Ousmane Sembène at 100: A Tribute to Senegal’s ‘Father of African Cinema’
Inside an Ultra-exclusive Lodge on the Fringe of Etosha National Park
Tourists Flock to Nigerian Cave And Waterfall For Its ‘Healing Powers’
Morocco is Just as Worthy for a Sun Trip
African Markets Offer Unique Goods and Experiences
Get to Know East Africa’s Art Scene
Mo Ibrahim’s Index Looks at Africa’s State of Governance
France to Give Burkina Faso What It Wants